Regencell Bioscience (RGC) had the best month last year by a large-cap US stock in May 2025, returning 1,494.3%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Regencell Bioscience (RGC) | May 2025 | 1,494.29% |
Regencell Bioscience (RGC) | March 2025 | 593.31% |
Circle Internet (CRCL) | June 2025 | 484.81% |
Figma (FIG) | July 2025 | 250% |
CoreWeave, Inc Class A Common Stock (CRWV) | May 2025 | 136.7% |
Sandisk (SNDK) | September 2025 | 119.96% |
EchoStar (SATS) | August 2025 | 109.85% |
Ast Spacemobile (ASTS) | June 2025 | 103.39% |
Regencell Bioscience (RGC) | April 2025 | 83.98% |
IREN (IREN) | September 2025 | 83.39% |
Regencell Bioscience (RGC) | December 2025 | 82.45% |
Sandisk (SNDK) | October 2025 | 76.3% |
IREN (IREN) | June 2025 | 74.28% |
IREN (IREN) | August 2025 | 73.13% |
Warner Bros Discovery (WBD) | September 2025 | 72.83% |
Nebius (NBIS) | September 2025 | 70.36% |
Rocket Lab USA (RKLB) | December 2025 | 69.53% |
Tempus AI, Inc Class A Common Stock (TEM) | January 2025 | 69.34% |
Bloom Energy (BE) | September 2025 | 69.14% |
Guardant Health (GH) | August 2025 | 65.45% |
Bloom Energy (BE) | August 2025 | 61.7% |
Bloom Energy (BE) | October 2025 | 59.86% |
Bloom Energy (BE) | July 2025 | 59.65% |
Bullish (BLSH) | August 2025 | 59.54% |
Advanced Micro Devices (AMD) | October 2025 | 59.15% |
Large-cap stocks are treated as having a market cap of $10B+.
